Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Cytovation raises funds to advance CyPep-1

July 4, 2017

Endpoints met in Lee's phase Ib/IIa study of adapalene/clindamycin gel for acne

June 30, 2017

Small-molecule SIK1 inhibitors for topical induction of UV-independent skin pigmentation

June 29, 2017

Devonian to begin testing Thykamine in atopic dermatitis

June 26, 2017

Bristol-Myers Squibb TYK2 inhibitor BMS-986165 promising in phase I trial

June 19, 2017

Novartis discloses Janus kinase inhibitors

June 15, 2017

BioTime's pivotal European trial of Renevia meets primary endpoint

June 15, 2017

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

June 14, 2017

Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa

June 13, 2017

First patient enrolled in DELIVERS trial of Castle Creek Pharmaceuticals' CCP-020

June 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026